Abstract
In acute myelogenous leukemia, the persistent detection of abnormal cytogenetics at complete remission (ACCR) is associated with inferior outcomes. However, the prognostic significance of ACCR in adult patients with acute lymphoblastic leukemia (ALL) is unknown. We evaluated 272 adult patients with ALL and abnormal cytogenetics at baseline who were treated with frontline induction chemotherapy, achieved complete remission (CR) and had cytogenetic analysis performed at the time of CR. ACCR was observed in 26 patients (9.6%). Median relapse-free survival was 22 months (95% CI, 12 months to not reached) for patients with ACCR vs. 48 months (range, 30-125 months) in patients with normal cytogenetics at CR (NCCR; P = 0.31). Median overall survival also did not differ significantly between the ACCR (99 months [range, 17 months to not reached]) and NCCR groups (67 months [range, 47 months to not reached], P = 0.86). The specificity of ACCR for minimal residual disease (MRD) positivity by multi-parameter flow cytometry (MFC) was 43%, and there was overall poor correlation between these two methods for the detection of residual disease. When patients were stratified by MRD status, the presence or absence of persistent cytogenetic abnorm...Continue Reading
References
Jun 1, 1997·Bone Marrow Transplantation·D GrimwadeA Goldstone
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J NachmanM E Trigg
May 21, 1998·Leukemia·T M SchenkM Andreeff
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KantarjianE J Freireich
Sep 1, 2001·British Journal of Haematology·M LübbertA Ferrant
Feb 6, 2003·Cancer·Hagop M KantarjianMoshe Talpaz
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guido MarcucciClara D Bloomfield
Dec 16, 2006·Blood·Anthony V MoormanUNKNOWN Adult Leukaemia Working Party, Medical Research Council/National Cancer Research Institute
May 12, 2009·Leukemia Research·Sebastian BalleisenUlrich Germing
Oct 17, 2009·Haematologica·Dragana MilojkovicDavid Marin
Oct 30, 2009·British Journal of Haematology·Bella PatelLetizia Foroni
Feb 11, 2010·Haematologica·Albert OriolUNKNOWN Programa Español de Tratamiento en Hematologia Group
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yiming ChenFarhad Ravandi
Aug 2, 2011·Blood·Elias JabbourJorge Cortes
Mar 14, 2012·British Journal of Haematology·Jonathan I SiveAnthony H Goldstone
Oct 4, 2012·Blood·Monika BrüggemannMichael Kneba
Jan 16, 2013·Clinical Lymphoma, Myeloma & Leukemia·Elias JabbourJorge Cortes
Feb 8, 2013·Journal of Hematology & Oncology·Koji NagafujiMine Harada
Jul 10, 2013·Blood·Farhad RavandiHagop M Kantarjian
Nov 28, 2013·Blood·Adele K FieldingAnthony H Goldstone
Apr 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josep-Maria RiberaEvarist Feliu
Jan 15, 2015·Blood·Nathalie DhédinUNKNOWN GRAALL group
Apr 23, 2015·Thoracic Surgery Clinics·Douglas E Wood